SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,106.65 107.25
( 0.13%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

58,738.13 1,303.36
(2.27%)

Nikkei 225

10,779.79 105.85
(0.99%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bacil Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524516

INE711D01018

17.8742423

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

38.73

24.46

EPS(TTM)

Face Value()

Div & Yield %

0.44

Back

Bacil Pharma reports standalone net loss of Rs 0.01 crore in the September 2026 quarter

Oct 15,2026

Net loss of Bacil Pharma reported to Rs 0.01 crore in the quarter ended September 2026 as against net profit of Rs 0.01 crore during the previous quarter ended September 2025. There were no Sales reported in the quarter ended September 2026 and during the previous quarter ended September 2025.

81,106.65 107.25 ( 0.13%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

58,738.13 1,303.36 (2.27%)

10,779.79 105.85 (0.99%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)